Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minidosing LSD for Chronic Cluster Headache
2024-520305-39-00Phase 2Authorised
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Cluster Headache (CH) comparing Lysergide minidose with Placebo (2 arms). Primary endpoint: Change in weekly attack frequency at week 3. Planned start Jan 2025; status: authorised.
02
Drugs
Lysergide
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on 2024-520305-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520305-39-00.